Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology

Trends in Molecular Medicine

Volumn 7, Issue 8, 2001, Pages 345-350

  Semenza, Gregg L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1;

ANGIOGENESIS; BRAIN ARTERY; BRAIN ISCHEMIA; CELL CULTURE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; ISCHEMIC HEART DISEASE; LUNG RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PROTEIN INTERACTION; PULMONARY HYPERTENSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034901463     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02090-1     Document Type: Review

References (90)

1. 2 tension
2. Remembrance of things PAS: Regulation of development by bHLH-PAS proteins
3. The basic helix-loop-helix-PAS protein MOP9 is a brain-specific heterodimeric partner of circadian and hypoxia factors
4. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia
5. Expression of ARNT, ARNT2, HIF1α, HIF2α and Ah receptor mRNAs in the developing mouse
6. In vivo expression of mRNAs encoding hypoxia-inducible factor 1
7. Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT)
8. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt)
9. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development
10. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels
11. Endothelial PAS domain protein I (EPAS1), a transcription factor selectively expressed in endothelial cells
12. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development
13. 2 homeostasis by hypoxia-inducible factor 1α
14. ARNT-deficient mice and placental differentiation
15. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
16. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling
17. HIF-1α is required for solid tumor formation and embryonic vascularization
18. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: Comparison with hypoxia-inducible factor-1α
19. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1α and the HIF-like factor
20. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
21. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein
22. Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia
23. Hypoxia-inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
24. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
25. 2-dependent degradation domain via the ubiquitin-proteasome pathway
26. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway
27. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: Its stabilization by hypoxia depends on redox-induced changes
28. Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
29. 2 sensing
30. Evidence for the involvement of diacylglycerol kinase in the activation of hypoxia-inducible transcription factor-1 by low oxygen tension
31. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1
32. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
33. Loss of PTEN facilitates HIF-1-mediated gene expression
34. Nitric oxide contributes to behavioral, cellular, and developmental responses to low oxygen in Drosophila
35. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
36. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: Redox-dependent effect of nitrogen oxides
37. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
38. Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1
39. Early expression of angiogenesis factors in acute myocardial ischemia and infarction
40. Age-dependent impairment of angiogenesis
41. The function of hypoxia-inducible factor 1 (HIF-1) is impaired in senescent mice
42. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity
43. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation
44. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1α/VP16 hybrid transcription factor
45. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain
46. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumour angiogenesis
47. Hypoxia-inducible factor 1α mediates hypoxia-induced delayed neuronal death that involves p53
48. Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase
49. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene
50. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
51. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells
52. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
53. HIF-1: Using two hands to flip the angiogenic switch
54. Overexpression of HIF-1α in breast carcinogenesis
55. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
56. Expression of hypoxia-inducible factor 1α in human brain tumors: Association with angiogenesis, invasion, and progression
57. Expression of hypoxia-inducible factor-1a: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer
58. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression
59. Suppression of tumor growth through disruption of hypoxia-inducible transcription
60. Hypoxia-inducible factor I modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
61. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth
62. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1α hypoxia response element: VEGF cascade differentially regulates vascular response and growth rate in tumors
63. 3
64. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia
65. Hypoxia inducible factor 1α is increased in ischemic retina: Temporal and spatial correlation with VEGF expression
66. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1α-subunit (HIF-1α): Characterization of HIF-1α-dependent and independent hypoxia-inducible gene expression
67. 1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle
68. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes
69. Hypoxia-inducible expression of tumor-associated carbonic anhydrases
70. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency
71. Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand
72. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1
73. Hypoxia-inducible factor 1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia
74. Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
75. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1
76. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia
77. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1
78. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes
79. Hypoxic induction of prolyl 4-hydroxylase α(I) in cultured cells
80. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor 1
81. Identification of a hypoxia response element in the transferrin receptor gene
82. Transferrin receptor induction by hypoxia: HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation
83. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes: Flt-1, but not Flk-1/KDR, is upregulated by hypoxia
84. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1α
85. Molecular mechanisms of transcription activation by HLF and HIF-1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300
86. Transitional change between HIF-1 and HNF-4 in response to hypoxia
87. Functional interference between hypoxia and dioxin signal transduction pathways: Competition for recruitment of the Arnt transcription factor
88. Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway
89. Stabilization of wild-type p53 by hypoxia-inducible factor 1α
90. An essential role for p300/CBP in the cellular response to hypoxia